116 related articles for article (PubMed ID: 2783668)
1. Irreversible ocular toxicity from single "challenge" dose of deferoxamine.
Bene C; Manzler A; Bene D; Kranias G
Clin Nephrol; 1989 Jan; 31(1):45-8. PubMed ID: 2783668
[TBL] [Abstract][Full Text] [Related]
2. [Retinal pigment epithelium--desferal].
Roulez F
Bull Soc Belge Ophtalmol; 2007; (304):59-66. PubMed ID: 17718228
[TBL] [Abstract][Full Text] [Related]
3. [Ocular toxicity of deferoxamine: description and analysis of three observations].
Szwarcberg J; Mack G; Flament J
J Fr Ophtalmol; 2002 Jun; 25(6):609-14. PubMed ID: 12223949
[TBL] [Abstract][Full Text] [Related]
4. Desferrioxamine in the treatment of aluminum overload.
Ackrill P; Day JP
Clin Nephrol; 1985; 24 Suppl 1():S94-7. PubMed ID: 3842106
[TBL] [Abstract][Full Text] [Related]
5. [Severe ocular toxicity of desferrioxamine in the hemodialyzed patient].
Bournerias F; Monnier N; Dufier JL; Réveillaud RJ
Nephrologie; 1987; 8(1):27-9. PubMed ID: 3587485
[TBL] [Abstract][Full Text] [Related]
6. Comment on "Irreversible ocular toxicity from single challenge dose of desferrioxamine" by C. Bene et al.
Yaqoob M; Prabhu P; Ahmad R
Clin Nephrol; 1991 Sep; 36(3):155. PubMed ID: 1934674
[No Abstract] [Full Text] [Related]
7. Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population.
Baath JS; Lam WC; Kirby M; Chun A
Retina; 2008 Jun; 28(6):894-9. PubMed ID: 18536609
[TBL] [Abstract][Full Text] [Related]
8. Ocular and auditory toxicity of long-term, high-dose subcutaneous deferoxamine therapy.
Orton RB; de Veber LL; Sulh HM
Can J Ophthalmol; 1985 Jun; 20(4):153-6. PubMed ID: 4052864
[TBL] [Abstract][Full Text] [Related]
9. Desferrioxamine related maculopathy: a case report.
Arora A; Wren S; Gregory Evans K
Am J Hematol; 2004 Aug; 76(4):386-8. PubMed ID: 15282675
[TBL] [Abstract][Full Text] [Related]
10. Deferoxamine for the treatment of hemosiderosis during CAPD.
Gomez RA; Campbell F; Savory J; Chevalier RL
Int J Pediatr Nephrol; 1987; 8(1):21-4. PubMed ID: 3583552
[TBL] [Abstract][Full Text] [Related]
11. [Chronic aluminum poisoning in continuous ambulatory peritoneal dialysis: treatment with deferoxamine].
Passlick J; Wilhelm M; Busch T; Grabensee B; Ohnesorge FK
Dtsch Med Wochenschr; 1989 Feb; 114(7):253-7. PubMed ID: 2917487
[TBL] [Abstract][Full Text] [Related]
12. Aluminum and deferoxamine kinetics in CAPD.
Mactier RA
Adv Perit Dial; 1991; 7():26-9. PubMed ID: 1680440
[TBL] [Abstract][Full Text] [Related]
13. Deferoxamine for aluminum toxicity in dialysis patients.
Hernandez P; Johnson CA
ANNA J; 1990 Jun; 17(3):224-8. PubMed ID: 2357118
[TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of aluminum intoxication in chronic renal failure.
Simon P; Allain P; Ang KS; Cam G; Mauras Y
Adv Nephrol Necker Hosp; 1985; 14():439-78. PubMed ID: 3919543
[No Abstract] [Full Text] [Related]
15. Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
Sprague SM; Corwin HL; Wilson RS; Mayor GH; Tanner CM
Arch Intern Med; 1986 Oct; 146(10):2063-4. PubMed ID: 3767553
[TBL] [Abstract][Full Text] [Related]
16. [Indications for desferrioxamine in patients with chronic renal insufficiency treated by dialysis].
Simon P
Nephrologie; 1986; 7(5):177-80. PubMed ID: 3822038
[No Abstract] [Full Text] [Related]
17. Aluminum-related osteomalacia in renal-failure patients.
Vick KE; Johnson CA
Clin Pharm; 1985; 4(4):434-9. PubMed ID: 3899471
[TBL] [Abstract][Full Text] [Related]
18. [Ocular side effects of deferoxamine therapy in aplastic anemia with transfusion-induced hemochromatosis].
Spraul CW; Schicketanz C; Lang GE
Klin Monbl Augenheilkd; 1996 Jul; 209(1):31-6. PubMed ID: 8965474
[TBL] [Abstract][Full Text] [Related]
19. The role of desferrioxamine in dialysis-associated mucormycosis: report of three cases and review of the literature.
Boelaert JR; van Roost GF; Vergauwe PL; Verbanck JJ; de Vroey C; Segaert MF
Clin Nephrol; 1988 May; 29(5):261-6. PubMed ID: 3293856
[TBL] [Abstract][Full Text] [Related]
20. Long-term intraperitoneal deferoxamine for hemochromatosis.
Swartz RD; Legault DJ
Am J Med; 1996 Mar; 100(3):308-12. PubMed ID: 8629676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
